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Abstract Gly m Bd 28 K is a major soybean (Glycine
max Merr.) glycoprotein allergen. It was originally
identified as a 28 kDa polypeptide in soybean seed flour.
However, the full-length protein is encoded by an open
reading frame (ORF) of 473 amino acids, and contains a
23 kDa C-terminal polypeptide of as yet unknown
allergenic and structural characteristics. IgE-binding
(allergenic potential) of the Gly m Bd 28 K protein
including the 23 kDa C-terminal portion as well as
shorter fragments derived from the full-length ORF
were evaluated using sera from soy-sensitive adults. All
of these sera contained IgE that efficiently recognized the
C-terminal region. Epitope mapping demonstrated that
a dominant linear C-terminal IgE binding epitope re-
sides between residues S256 and A270. Alanine scanning
of this dominant epitope indicated that five amino acids,
Y260, D261, D262, K264 and D266, contribute most
towards IgE-binding. A model based on the structure of
the b subunit of soybean b-conglycinin revealed that Gly
m Bd 28 K contains two cupin domains. The dominant
epitope is on the edge of the first b-sheet of the C-ter-
minal cupin domain and is present on a potentially
solvent-accessible loop connecting the two cupin
domains. Thus, the C-terminal 23 kDa polypeptide of
Gly m Bd 28 K present in soy products is allergenic and
apparently contains at least one immunodominant epi-
tope near the edge of a cupin domain. This knowledge
could be helpful in the future breeding of hypoallergenic
soybeans.
Keywords Allergen Æ Cupin superfamily Æ Epitope
mapping Æ Glycine max Æ IgE-binding Æ Recombinant
fusion polypeptide
Abbreviations Ara h 1: Arachis hypogaea allergen
1 Æ Ara h 3: Arachis hypogaea allergen 3 Æ BCA:
Bicinchoninic acid Æ Gly m Bd 28 K: Glycine max: band
28 kDa allergen Æ Gly m Bd 30 K: Glycine max band
30 kDa allergen Æ Gly m Bd 68 K: Glycine max band
68 kDa allergen Æ IgE: Immunoglobulin E
Introduction
Soybean ranks among the eight most significant food
allergens (Pedersen 1988; Zeece et al. 1999) and is the
largest source of protein meal in the world (USDA-ERS
2003). Its wide usage in the food industry makes it dif-
ficult to eliminate from the diet of soy-sensitive indi-
viduals. Allergies to soybean have been increasingly
studied over the last decade (Herian et al. 1990;
Beardslee et al. 2000; Helm et al. 2000a, 2000b; Ogawa
et al. 2000; Gu et al. 2001). There has also been strong
interest in removing major allergens from soybeans,
through food processing (Ogawa et al. 2000), mutations
(Samoto et al. 1997; Ogawa et al. 2000) or through plant
transformation (Herman 2003; Herman et al. 2003). In
an elegant study, Herman et al. (2003) utilized plant
transformation techniques to develop soybean lines
essentially devoid of a major allergen: Gly m Bd 30 K.
The transformed lines were essentially identical to non-
transformed plants (Herman et al. 2003), raising the
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possibility of successfully engineering hypoallergenic
elite lines in the near future. However, as pointed out
succinctly by Herman (2003), there are many other
hurdles that have yet to be overcome before genetically
modified hypoallergenic food crops are grown com-
mercially.
Soybean seeds contain many proteins of varying
allergenicity. These include the G1 and G2 glycinin
proteins, Gly m Bd 30 K (a thiol protease-like 34 kDa
protein), Gly m Bd 68 K (the 70 kDa a-subunit of
b-conglycinin) and Gly m Bd 28 K (Beardslee et al.
2000; Helm et al. 2000a, 2000b; Ogawa et al. 2000;
Xiang et al. 2002). While all of these allergens have
been studied to different extents, several important
allergenic features of Gly m Bd 28 K have not yet
been evaluated.
Gly m Bd 28 K was first isolated from soybean meal
as a 28 kDa glycosylated protein (Tsuji et al. 1997). It
was later demonstrated that it had a single glycosyla-
tion site, with an N-linked glycan moiety attached to
Asn—the 20th amino acid in the purified protein
(Hiemori et al. 2000). Interestingly, the cloning of the
cDNA for Gly m Bd 28 K has shown that the protein
is about twice as large as anticipated from its initial
discovery as a 28 kDa polypeptide on SDS gels (Tsuji
et al. 2001). The full open reading frame (ORF) coding
for Glym Bd 28 K consists of a preproprotein of 473
amino acids, with a predicted 21 amino acid signal
peptide. Overall, Gly m Bd 28 K shares significant
homology with the pumpkin MP27/MP32 protein
(50.4% identity) and a carrot globulin-like protein,
Gea8 (45.9% identity). The Gly m Bd 28 K proprotein
is suggested to be further processed in the seed into two
mature proteins, an N-terminal polypeptide of about
240 amino acids and a C-terminal polypeptide of about
212 amino acids, in a manner similar to the processing
of the pumpkin MP27/MP32 proprotein (Tsuji et al.
2001).
The allergenic potential of Gly m Bd 28 K has been
demonstrated by elevated serum IgE binding ability in
patients with soy sensitivities. To date, most of the
IgE-binding studies to Gly m Bd 28 K have been
limited to the N-terminal, approximately 240 residue,
fragment initially purified from soybean seeds (Tsuji
et al. 1997, 2001; Heimori et al. 2000). In one study,
the N-linked carbohydrates on this polypeptide
apparently exhibited greater IgE-binding within the
sera tested than the deglycosylated amino acid back-
bone (Heimori et al. 2000). However, IgE binding to
this protein could not be fully abolished by the inhi-
bition of the IgE binding to its glycan moiety (Hei-
mori et al. 2000). Furthermore, a recombinant
polypeptide, corresponding to Phe22–Lys259 of the
full length Gly m Bd 28 K ORF still retained signifi-
cant IgE binding ability (Tsuji et al. 2001). These data
indicated that the deglycosylated N-terminal polypep-
tide of Gly m Bd 28 K contained IgE-binding epitopes
and potentially contributed to the allergic responses
documented in vivo. Since the discovery of the C-
terminally cleaved region of Gly m Bd 28 K, however,
no further studies have investigated the allergenicity,
IgE-binding or predicted tertiary structure of this
approximately 212 amino acid novel polypeptide.
In this paper, we have dissected the potential linear
allergenic domains of Gly m Bd 28 K beginning with the
recombinant, full-length, 473 residue proprotein. Over-
lapping fragments spanning N-terminal and C-terminal
portions of the Gly m Bd 28 K protein were con-
structed, and their IgE binding abilities were evaluated
using sera from soybean-sensitive individuals. We have
demonstrated that both the N- and C-terminal frag-
ments of Gly m Bd 28 K can bind IgE, and have char-
acterized a novel dominant sequential epitope on the C-
terminal fragment of the protein. The Gly m Bd 28 K
allergen is probably processed into two smaller poly-
peptides of 240 and 212 amino acids in the soybean seed,
and both portions are expected to be present in soybean-
derived foods. Our data suggest that the C-terminal
polypeptide has been an overlooked contributor to
soybean sensitivities. This hypothesis is supported by
sequence alignments of Gly m Bd 28 K with members of
the cupin family, which contain several known plant
allergens (Mills et al. 2002). We have also generated a
homology model of Gly m Bd 28 K and found that the
novel, dominant, IgE-binding epitope identified in this
work may reside on the edge of a loop region that
connects the two cupin domains. This position may
contribute to its allergenic potential through enhanced
surface exposure.
Materials and methods
Construction of recombinant fusion proteins
of Gly m Bd 28 K
The cDNA clone of Gly m Bd 28 K was obtained from
Pioneer Hybrid (generous gift of Rudolf Jung, Pioneer
Hybrid, Des Moines, Iowa). This clone starts at a Met,
which corresponds to the 20th amino acid in the se-
quence reported by Tsuji et al. (2001; DDBJ accession
no. AB046874). In addition, our clone has two sequence
differences, namely, R4 and K333 based upon the
starting residue of our clone, which correspond to H23
and R352, respectively, in the sequence reported by Tsuji
et al. (2001).
Eight thioredoxin-fusion proteins representing
Gly m Bd 28 K and overlapping fragments of Gly m Bd
28 K were constructed. PCR primers (P28FNDEI,
5¢-catatggccttccgtgatg; P28RECORI, 5¢-gaattcaaaaacat-
ccataacca; P28F1R231, 5¢-gaattccctccatgacctactt; P28F-
2M215, 5’-catatgcaagaccaagaggagg; P28F11L120,
5¢-gaattcaagtctctgaccttctcct; P28F3L100, 5¢-catatgttgta-
catgattccatctggt; P28F3F345, 5¢-gaattcaaacacgtcccctt;
P28F13F45, 5¢-gaattcaaatatcctaccacca; P28F14M40, 5¢-
catatgcatggtggtaggatattt; P28F14L100, 5¢-gaattccaagtc-
ccctgtctt) were designed for read-through, and all
primers were synthesized by Sigma-Genosys (The
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Woodlands, Tex.). PCR reactions were performed for 35
cycles using Taq DNA polymerase (Gibco-BRL). PCR
products were purified from 1% agarose gels and ligated
into the pBAD/TOPO vector using the TA system (In-
vitrogen). The ligated DNA was transformed into Esc-
herichia coli Top10 cells following the manufacturer’s
recommended protocols (Invitrogen). Constructs con-
taining inserts with the predicted sizes and correct ori-
entation were verified through endonuclease mapping
and sequenced in the Genomics Core Research Facility
of the University of Nebraska-Lincoln.
Expression and purification of recombinant
Gly m Bd 28 K proteins
E. coli containing the appropriate constructs were grown
in 5 ml LB medium containing ampicillin (50 lg/ml)
overnight at 37C, and used to inoculate 250 ml LB
medium containing ampicillin (50 lg/ml). Cultures were
grown at 37C with shaking at 200 rpm until the OD600
reached approximately 0.5. At that time, cells were in-
duced with 0.02% L-arabinose. Cells were grown for an
additional 3–4 h at 37C, and harvested by centrifuga-
tion at 5,000 g for 5 min at 4C. Purification of the re-
combinant proteins was as described earlier (Beardslee
et al. 2000; Xiang et al. 2002). Fusion protein purity was
evaluated by SDS-PAGE as described below. Protein
concentrations were determined by the BCA assay
(Pierce). Purified proteins were stored in aliquots at
20C until used.
Electrophoretic separation
Aliquots containing 4 lg of each recombinant protein
were analyzed by SDS-PAGE on 12.5% SDS gels
(Laemmli 1970). Proteins were stained with 0.1% Coo-
massie Brilliant Blue R-250.
Human sera
Sera from adult soybean-allergic patients with high
soybean specific IgE levels were purchased from Plasma-
Labs (Everett, Wash.). All of these adult individuals had
given consent (to Plasma Labs) for collection of their
plasma for research studies, and were found to be allergic
to soy and peanut extracts by a skin-prick test. Sera from
people with high IgE level but no reported soybean
allergic reactions or those lacking soybean specific IgE
were used as negative controls (Xiang et al. 2002).
Immunoblotting
Proteins separated by SDS-PAGE were transferred to
polyvinylidene fluoride membranes (Millipore, Immo-
bilon-P) in a tank apparatus overnight at 20 V in
transfer buffer (10 mM Tris-HCl, 100 mM glycine, 10%
methanol) at 4C. Membranes were probed with sera
and antigen-antibody complexes were detected essen-
tially as described previously (Xiang et al. 2002).
Peptide synthesis on SPOT membrane
Individual peptides were synthesized on a modified
SPOT cellulose membrane (Sigma-Genosys) containing
free hydroxyl groups using Fmoc amino acids as de-
scribed previously (Xiang et al. 2002). Peptide-containing
membranes were stored at 20C until needed or used
directly for the IgE-binding assay as described below.
IgE-binding assay of SPOT membrane
The SPOT membrane containing synthetic peptides was
washed with Tris-buffered saline (TBS) and blocked
overnight at 4C with blocking buffer [TBST (TBS-
Tween 20) containing 5% sucrose and 2· membrane
blocking buffer from Sigma-Genosys]. The membrane
was incubated overnight at 4C with the appropriate
human serum diluted 1:3 in blocking buffer, washed in
TBST and incubated with goat anti-human IgE-horse-
radish peroxidase (Bethyl-Labs, Montgomery, Tex.) di-
luted to 0.15 lg/ml in blocking buffer and developed
using chemiluminescence.
Sequence analysis and model construction
of Gly m Bd 28 K
Pfam searches of Gly m Bd 28 K sequence were con-
ducted using Pfam 8.0 (http://pfam.wustl.edu/hmm-
search.shtml; Bateman et al. 2002). Similarity searches
of Gly m Bd 28 K sequence were performed using
BLAST 2 from NCBI (http://www.ncbi.nlm.nih.gov/).
A tentative model of the Gly m Bd 28 K structure was
generated using the 3D-PSSM server (Kelley et al. 2000).
3D-PSSM was the only automated modeling program
that preserved the alignment of Gly m Bd 28 K with
known cupin domains. Of the models generated by 3D-
PSSM, we chose the one based upon the b-conglycinin
structure (PDB identifier 1ipj; Berman et al. 2000;
Maruyama et al. 2001). We used percent identity and
similarity to infer homology, and utilized the power of
the 3D-PSSM server to model distant homologs of
proteins. Although speculative, our models based upon
these distant homologs provides insights into the struc-
ture and function of these new, relatively uncharacter-
ized proteins.
Results
Construction, expression and purification
of recombinant Gly m Bd 28 K
Recombinant Gly m Bd 28 K and its fragment proteins
were constructed as thioredoxin fusions, and contained a
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6· histidine tag at their C-termini. The respective frag-
ment lengths and position on the intact protein are
shown in Fig. 1. Based on a predicted processing site
between N242 and E243 (Tsuji et al. 2001), and the
initial discovery of this allergen as an approximately
28 kDa protein, we first constructed two fusion frag-
ments: f1 (the N-terminal 231 residues) and f2 (the C-
terminal 240 residues). Initial experiments revealed that
both fragments bound to IgE from sera of soy-allergic
individuals. To learn more about the IgE binding of
these two fragments, several smaller and overlapping
fusions were also generated. Purity of all recombinant
proteins was verified by SDS-PAGE, and generally
exceeded 90% (Fig. 2a).
Identification of IgE binding regions by immunoblotting
Sera from eight soy-sensitive patients were tested; six of
these contained IgE antibodies recognizing recombinant
Gly m Bd 28 K. One of the sera also bound strongly to
the thioredoxin fusion partner and was not studied
further. The other five sera were tested for their recog-
nition of the recombinant Gly m Bd 28 K and its frag-
ments. A representative immunoblot obtained using one
of the five sera from soy-sensitive patients is shown in
Fig. 2b. Individual sera were tested for the presence of
IgE directed towards different portions of the Gly m Bd
28 K protein. The developed X-ray films were scored
independently by the authors, who compared and scored
the relative density obtained for each fragment from the
six immunoblots on a scale of 4 (high) to 0 (negligible)
and the pooled data were averaged. The average quali-
tative scores are shown in Table 1. Generally, there was
negligible or very weak response of these soybean-sen-
sitive sera to the thioredoxin fusion partner. The non-
allergic sera used as a control did not detect any of the
target Gly m Bd 28 K fragments tested, confirming that
reactivity of the sera to Gly m Bd 28 K correlates to soy
sensitivities in human patients.
The profile of IgE-binding to the Gly m Bd 28 K
fragments showed that both the 231 residue N-terminal
region, f1, and the 240 residues C-terminal fragment, f2,
contributed to observed IgE binding of the full-length
protein, indicating that epitopes existed in both halves of
the allergen. Based upon the binding frequency and
relative densities scored from immunoblots, the C-ter-
minal f2 region appeared to display stronger IgE binding
than the N-terminal f1 region (Table 1). This finding
was novel, since this was the first observation of IgE
binding to the C-terminal fragment. We next narrowed
the region of the polypeptide that contained IgE-binding
domains. Fragment f11 (encompassing the first 120
residues from the N-terminus) bound to IgE in sera from
soy-sensitive individuals, as did fragment f3 (residues
L100–F345); however, fragment f12 (residues L100–
R231) did not bind to IgE with significant avidity. These
results indicate that IgE binding epitope(s) are located
within the first 120 amino acids from the N-terminus,
and for the first time indicated IgE-binding sites present
between residues 231 and 345 of the full-length Gly
m Bd 28 K protein.
We also performed less detailed studies of the N-
terminal epitope binding region. These analyses re-
vealed that IgE-binding to residues M1–M40 (fragment
Fig. 1 Construction of recombinant proteins based on the
sequence of Gly m Bd 28 K. Each construct contains a 13 kDa
thioredoxin fusion partner on the N-terminus and a 3 kDa 6· His
tag on the C-terminus. For simplicity, the fusion partners are
indicated for the full-length Gly m Bd 28 K construct and omitted
on other constructs in this figure
Fig. 2 a SDS-PAGE of purified recombinant Gly m Bd 28 K and
its fragments. b Representative immunoblot of recombinant Gly
m Bd 28 K and its fragments with a serum sample from a soybean-
sensitive individual (#1); 4 lg of each polypeptide was loaded and
separated on a 12.5% polyacrylamide gel. Immunoblotting was
performed as described in Materials and methods. Lanes: 1 Full
length protein; 2–8 fragments f1, f2, f11, f3, f12, f13, f14,
respectively; 9 thioredoxin
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f13) was relatively weak, whereas much greater binding
(on average) of IgE to fragment f14 (M40–L100) was
documented for the five soy-sensitive sera tested
(Table 1). These results indicate that strong IgE
binding epitope(s) exist between residues M40 and
L100 of Gly m Bd 28 K.
The novel, potentially strong, allergenic region of the
C-terminal portion of the full-length Gly m Bd 28 K
molecule was mapped in greater detail and is described
in the following sections.
IgE binding epitopes in the C-terminal fragment
The documentation of strong IgE-binding in an as yet
undocumented portion of the allergen permitted us to
identify the IgE binding epitope(s) within the C-termi-
nal portion of Gly m Bd 28 K. We tested IgE binding
of the region encompassing residues E221 to C353,
which contains the relatively strong IgE-binding do-
mains documented for fragment f2 and f3 (Table 1).
Eighteen 15-mer peptides designed with 8 amino acid
overlap were synthesized on modified cellulose paper
and probed with an aliquot of soy-sensitive sera ob-
tained by pooling equal amounts of sera from the five
soy-sensitive individuals (see Table 1). Only one pep-
tide, peptide 6, corresponding to the region S256–A270
of Gly m Bd 28 K, exhibited strong IgE binding
(Fig. 3).
Alanine scanning of the C-terminal epitope
To identify the amino acids critical for IgE binding in
peptide 6, a series of related peptides were synthesized
on a SPOT membrane with alanine substitutions at each
position of the 15-mer epitope, and their IgE binding
abilities evaluated (Fig. 4). Of the 15 amino acids on this
IgE epitope, alanine substitutions at Y260, D261, D262
and K264 essentially abolished binding to the IgE
present in the pooled soy-sensitive sera, whereas sub-
stitution of D266 with alanine greatly decreased IgE
binding. Thus, the central IgE-binding region of this
peptide is localized between Y260 and D266. The amino
acids most critical for IgE binding were identified as
Y260, D261, D262 and K264. However, residue D266
also contributed towards IgE binding.
Sequence analysis and model construction
of Gly m Bd 28 K
Sequence analysis indicated that Gly m Bd 28 K belongs
to the cupin superfamily and contains two cupin do-
mains, as has been documented for several legume
protein allergens (Mills et al. 2002). The cupin domains
span residues F18–S148 near the N-terminal end and
Y257–R407 near the C-terminal portion of the full-
length protein. Therefore, processing by cleavage at
residue 242, as predicted to occur in soybeans (Tsuji
et al. 2001), would yield two proteins, each containing
one cupin domain.
Table 1 IgE binding ability of
recombinant full-length Gly
m Bd 28K and fusion
fragments. Relative density
rating: 0 no significant IgE
binding, 1 weak IgE binding, 2
moderate IgE binding, 3 strong
IgE binding, 4 very strong IgE
binding
Relative density of immunoblot
Fragment name Full-length f1 f2 f11 f3 f12 f13 f14
Fragment region 1–454 1–231 215–454 1–120 100–345 100–231 1–45 40–100
Serum #1 3 3 4 3 3 1 1 3
Serum #2 3 3.5 4 4 3 2 2 3
Serum #3 1.5 3 3 2 2.5 1.5 1.5 2.5
Serum #4 1 0.5 2 0.5 0.5 0 0 0.5
Serum #5 2.5 1 3 0.5 3.5 0 0 1
Nonallergic sera 0 0 0 0 0 0 0 0
Fig. 3 Epitope mapping of Gly m Bd 28 K C-terminal IgE-
binding region E221–C353. Eighteen 15-mer peptides representing
the region E221–C353 were manually synthesized on a SPOT
membrane as described in Materials and methods. Adjacent
peptides had an eight amino acid overlap. The membrane was
probed with a pool of soybean-sensitive sera and bound IgE was
detected by chemiluminescence using a goat anti-human IgE-
horseradish peroxidase conjugate. Peptide 6 (bold, underlined),
corresponding to residues S256–A270 of Gly m Bd 28 K protein,
exhibited strong IgE binding
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A tentative model of the Gly m Bd 28 K structure
was generated by 3D-PSSM (Kelley et al. 2000), using
soybean b-conglycinin as a template for the new struc-
ture (Fig. 5a). This model was chosen because the
b-conglycinin sequence gave the best alignment with Gly
m Bd 28K in the cupin domains. In this model, the
dominant IgE-binding epitope (S256–A270) present on
the C-terminal half of the protein is expected to be near
the beginning of the C-terminal cupin domain, and is
colored green in Fig. 5b. Interestingly, this IgE-binding
epitope in the C-terminal domain of Gly m Bd 28 K
occurs in a similar position to two epitopes of a
peanut cupin allergen, Ara h 1 (epitope 14, D393–E402
and epitope 15, N409–K418) identified by Shin et al.
(1998).
Discussion
In this study, we have identified two major IgE-binding
sites in Gly m Bd 28 K using recombinant fusion frag-
ments designed from the entire ORF and sera from
soybean-sensitive patients. Based on the intensity and
binding frequency of IgE in sera obtained from soybean-
sensitive individuals, the C-terminal half of Gly m Bd
28 K showed slightly stronger binding as compared
to the N-terminal half of this protein. Furthermore,
using synthetic peptides, we located an important IgE
binding region in the C-terminal 23 kDa polypeptide
of Gly m Bd 28 K, spanning residues S256–A270
(SYNLYDDKKADFKNA). The residues important
for IgE-binding on this epitope were identified through
alanine scanning and shown to be Y260, D261, D262,
K264 and D266. Since all of these residues are in the
middle of the epitope, it probably explains why the
peptides corresponding to D249-K263 and K263–L277,
which are adjacent in the linear sequence of the protein
to this epitope, did not show IgE binding (Fig. 3).
Finding a dominant allergenic epitope in proteins is not
unusual (Xiang et al. 2002); however, it is known that
Gly m Bd 28 K also contains strong IgE-binding regions
in the N-terminal half of the protein, and other epitopes
with less affinity for IgE binding (Ogawa et al. 2000; see
also Table 1, Fig. 2, this work). The expectation is that
each allergic individual will have a unique signature of
Fig. 4 Alanine scanning of residues important for IgE-binding in
peptide 6 shown in Fig. 3. Fifteen peptides designated as spots 1–15
were manually synthesized on a SPOT membrane. Peptides 1 and 6
represented the wild type sequence. Alanine substitutions are
underlined and in bold. The membrane was probed with the
soybean-sensitive sera (1:3 dilution) and bound IgE was detected as
described in Fig. 3
Fig. 5a,b A putative model of Gly m Bd 28 K based on the solved
structure of the b-subunit of soybean b-conglycinin. a Sequence
alignment of Gly m Bd 28 K (P28) to the b-subunit of soybean
b-conglycinin (Con). Asterisks Residues identical in all aligned
sequences, dots conserved residues. The aligned cupin domains are
shaded. Residues that were absent in the PDB 1IPK structure and
modeled using alanine placeholders are shown in lowercase italics.
b Ribbon diagram of a putative structure of Gly m Bd 28 K. The
two cupin domains are represented in blue and purple, respectively,
and the immunodominant epitope is highlighted in green
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epitope recognition, but that dominant epitopes will be
present for most allergenic proteins. Also, our mapping
methods were directed at linear epitopes and as such
would not have detected potential conformational epi-
topes. Future research using other methods could be
used to highlight both the linear and conformational
epitopes present on the entire Gly m Bd 28 K ORF.
Our results indicate that the sera used in this study
cross-reacted to the Gly m Bd 28 K C-terminal
portion of the protein, and efficiently recognized a
dominant linear epitope in this, as yet uncharacterized,
region of this known soy allergen. It is also possible
that the IgE would cross-react to other related
soybean and peanut proteins. As an example, we have
shown in a previous study that both soybean and
peanut glycinins contain a conserved IgE-binding epi-
tope (Xiang et al. 2002).
The strong IgE binding to the C-terminal portion of
Gly m Bd 28 K suggests that the two polypeptides
arising from the predicted processing of the full length
Gly m Bd 28 K (Tsuji et al. 2001) are present in soy-
bean-derived foods and elicit IgE production in soy-
bean-sensitive patients. This C-terminal polypeptide
derived from Gly m Bd 28 K has a predicted size of
23 kDa and a predicted pI of 5.62, which will place it in
a region where several abundant soybean proteins and
allergens, such as the soybean Kunitz trypsin inhibitor
and the basic chains of the glycinins (Burks et al. 1994;
Helm et al. 2000a, 2000b), would normally migrate in 1-
and 2-D gels. This may have precluded its prior identi-
fication as an IgE-binding protein in soy extracts and
would make its present direct identification in soybean
extracts quite challenging. The availability of IgG anti-
bodies specifically directed towards the 23 kDa fragment
should readily resolve this problem.
Interestingly, Gly m Bd 28 K belongs to the cupin
protein superfamily, which contains a number of
legume food allergens, such as the peanut Ara h 1,
Ara h 3, soybean b-conglycinin and soybean glycinin
G1 and G2 proteins (Mills et al. 2002). Most of these
food allergens contain two cupin domains, as we have
documented for Gly m Bd 28 K. Even though the
overall sequence identity between Gly m Bd 28 K and
other members of the cupin family is not high, Gly
m Bd 28 K clearly shares somewhat greater sequence
similarity to the 7S vicillin family, e.g., soybean
conglycinin (sequence identity of 23%) than to the 11S
legumin family, e.g., soybean glycinin (sequence iden-
tity of 20%). Thus, the modified structure of the
b-subunit of soybean b-conglycinin protein was used as
a template to model a potential structure of Gly
m Bd 28 K. However, the region linking the N- and
C-terminal cupin domains in Gly m Bd 28 K is longer
than most of the vicillins, and considerably longer than
the similar region of soybean b-conglycinin. This linker
region seems to be a hypervariable site among legume
seed storage proteins and contains specific sites for
proteolytic cleavage in vivo. For example, the soybean
glycinins are proteolytically processed in vivo in the
linker region joining the cupin domains to form the
acidic and basic chains of the mature proteins (Shutov
et al. 1995, 1996, 1998, 1999). Therefore, these regions
of plant cupin allergens could be points of attack in the
mammalian digestive tract, yielding potentially aller-
genic peptides.
The higher overall similarity of Gly m Bd 28 K to
the 7S vicillins, except for the extended linker region
between the two cupin domains, is also shared by two
other cupin family proteins, namely the MP27/MP32
precursor protein from pumpkin and the globulin-like
protein Gea8 from carrot (Shutov et al. 1998). To-
gether, these three related proteins may form a separate
branch in the seed storage globulin evolutionary tree
built by Shutov et al. (1998). The extended linker region
between the two cupin domains of these proteins may
be a prerequisite for the legumin-like processing, and
provide a site for proteolytic attack as occurs for the
MP27/MP32 precursor protein (Shutov et al. 1998). It is
still unclear if Gly m Bd 28 K is processed into two
separate polypeptides, and if these two chains are held
together by hydrophobic interactions as occurs for
soybean glycinins (Mills et al. 2002). However, the
recognition of both parts of the Gly m Bd 28 K protein
by IgE from soybean-sensitive individuals suggests that
they are indeed present in vivo. Furthermore, the C-
terminal epitope of Gly m Bd 28 K identified in this
work is at the beginning of the second cupin domain,
and near the predicted cleavage site (N242; Tsuji et al.
2001) of this protein. Structurally, this linker region
forms a small flat cavity between the two cupin domains
and the dominant epitope is expected to be surface ex-
posed (Fig. 5b). This type of structure may represent a
potential allergenic region in several proteins. For
example, two epitopes identified in the peanut allergen,
Ara h 1 (Shin et al. 1998) are also located in a partially
solvent exposed edge of the predicted cupin domain of
the Ara h 1 protein.
The detection of a novel IgE-binding epitope on the
C-terminal portion of the full-length Gly m Bd 28 K
protein suggests that soybean seeds could contain as yet
undocumented allergens. The presence of this and other
epitopes on partially solvent-exposed surfaces on several
legume cupin allergens might be indicative of regions on
these proteins that are more prone to becoming acces-
sible to the mammalian immune system following the
digestion process. It is known that cupin domains are
generally more resistant to proteolytic digestion (Mills
et al. 2002) and proteins with strong b-sheet structure,
such as the soybean Kunitz trypsin inhibitor, are quite
stable to a number of physical and chemical denaturants
(Roychaudhuri et al. 2003).
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